What the research says.
BPC-157 and TB-500 are experimental peptides. Here's what has been published about them in dogs, what's still unknown, and where to read the sources yourself.
BPC-157
A synthetic 15-amino-acid peptide based on a protein fragment found in the stomach lining. Most of the research is in rodents, looking at tendon, ligament, muscle, and gut tissue. It has more dog-specific data than TB-500, including safety and absorption studies in beagles.
TB-500
A synthetic peptide related to thymosin beta-4, a naturally occurring 43-amino-acid protein involved in cell movement and tissue remodeling. Products sold as TB-500 are often a short fragment rather than the full-length protein, which matters when comparing studies.
Used together, they're often called the “Wolverine stack.” No study has yet tested the combination in dogs under controlled conditions.
Published dog research
- 2020
Safety study in lab animals, including dogs
Researchers gave BPC-157 in single and repeated doses to mice, rats, rabbits, and beagle dogs. It was reported as well tolerated, with no serious toxic effects observed at the doses tested.
Read the source - 2022
How dogs absorb and clear BPC-157
A pharmacokinetic study in beagles found BPC-157 was absorbed quickly after intramuscular injection (about 45–51% bioavailability), had a half-life under 30 minutes, and was broken down into amino acids and cleared through urine and bile.
Read the source - 2024
A published veterinary case series
A veterinarian described four dogs with knee (stifle) problems managed without surgery: a 6-year-old Rottweiler, a 10-year-old Dachshund mix, an 11-year-old Jack Russell Terrier, and a 5-year-old Australian Shepherd. Each plan combined several therapies, including diet and weight management, supplements, physical therapy, laser therapy, and in some cases platelet-rich plasma, alongside BPC-157 alone or with TB-500. All four dogs regained function; the Rottweiler was running a mile at a follow-up about 2.5 years later.
Read the source
What researchers are studying
Most of this work is in cells and rodents, not dogs. These are the biological processes the peptides are being studied for:
- Tendon and ligament tissue
- New blood vessel formation
- Collagen-related repair
- Cell migration into injured tissue
- Tissue remodeling
- Inflammatory signaling
Dogs in the reports
These are owner accounts and published veterinary cases involving BPC-157 and TB-500 used together. None of these dogs were given AMBULO. They aren't controlled studies, results vary, and many dogs were getting other treatment at the same time, which we've noted where it was reported.
BPC-157 and TB-500 together
German Shepherd
Owner accountSevere hip instability
- Noticeably better movement within days
English Bulldog, 11
Owner accountHip mobility
- Moved more easily
- More active overall
English Labrador, 14
Owner accountArthritis and soft-tissue problems
- Better mobility and joint comfort
Boxer / Pit Bull mix, 12
Owner accountRecovery after surgery for a ruptured spleen
- Nearly back to normal activity after nine days
- Easier on stairs
Dachshund mix, 10
Published vet case, 2024Knee injury
- Bearing weight better and walking more normally
- Back to normal activity by about week 11
Australian Shepherd, 5
Published vet case, 2024Knee injury
- Better limb function and weight-bearing
- Steady return toward normal activity
Australian Shepherd
Owner account, 2026Partial cruciate ligament tear
- Owner estimated recovery at 85–90%
- Walking and moving better
Bella, 14
Owner account, September 2026Senior mobility
- Jogging again by about day five
- Willing to jump again
Two German Shepherds, both seniors
Owner account, October 2026Age-related mobility
- Considerably better mobility in both dogs
Two Shih Tzus, both elderly
Owner account, February 2026Skin irritation
- Less itching and visible irritation
- Possibly less coughing
What owners are noticing
Many of the most enthusiastic owner accounts online involve dogs aged 10 to 14. Owners describe everyday changes: longer walks, fewer stops, easier stairs, more play.
These are personal observations, not controlled studies, and most of the dogs were getting other care at the same time, like rehab, controlled exercise, or laser therapy.
Useful things to track
The same everyday measures owners describe are a good way to talk with your vet about changes over time.
- Distance walked
- Number of rest stops
- Willingness to take the stairs
- Getting up from lying down
- How often they play
- Putting weight evenly on each leg
Where the evidence stands
- No controlled clinical trials of BPC-157 or TB-500 have been completed in dogs.
- Neither compound is FDA-approved for use in animals.
- Doses used in research studies are not dosing guidance for your dog.
- Case reports and owner accounts are a starting point for research, not proof that something works.
- Talk with a licensed veterinarian before starting anything new.
Sources
- Xu C, et al. Preclinical safety evaluation of body protective compound-157. Regul Toxicol Pharmacol. 2020;114:104665.
- He L, et al. Pharmacokinetics, distribution, metabolism, and excretion of BPC157 in rats and dogs. Front Pharmacol. 2022;13:1026182.
- Watson SAM. An integrative approach to canine stifle injuries and degenerative conditions: four cases. J Am Holist Vet Med Assoc. 2024;77:26–38.